Rezolute, Inc. (RZLT)
NASDAQ·Healthcare·Biotechnology
$3.09
-6.80%
Mkt Cap $296.66M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | — | — | — | -$0.16 | -$0.22 | -37.50% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.27 | -$0.18 | +33.33% | — | — |
| Q3 2025 Sep 17, 2025 | — | — | — | -$0.23 | -$0.26 | -13.04% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.22 | -$0.27 | -22.73% | — | — |
| Q1 2025 Feb 12, 2025 | — | — | — | -$0.33 | -$0.22 | +33.33% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.35 | -$0.22 | +37.14% | — | — |
| Q3 2024 Sep 19, 2024 | — | $58.00K | — | -$0.30 | -$0.44 | -46.67% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.34 | -$0.34 | +0.00% | — | — |
| Q1 2024 Feb 13, 2024 | — | — | — | -$0.27 | -$0.27 | +0.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.33 | -$0.28 | +15.15% | — | — |
| Q3 2023 Sep 14, 2023 | — | — | — | -$0.34 | -$0.25 | +26.47% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.31 | -$0.30 | +3.23% | — | — |
| Q1 2023 Feb 10, 2023 | — | — | — | -$0.33 | -$0.26 | +21.21% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.31 | -$0.19 | +38.71% | — | — |
| Q3 2022 Sep 15, 2022 | — | — | — | -$0.34 | -$0.37 | -8.82% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.86 | -$0.65 | +24.42% | — | — |
| Q1 2022 Feb 9, 2022 | — | — | — | -$0.77 | -$0.80 | -3.90% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.90 | -$0.92 | -2.22% | — | — |
| Q3 2021 Sep 15, 2021 | — | — | — | -$0.82 | -$0.78 | +4.88% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$0.78 | -$0.44 | +43.59% | — | — |